1. Home
  2. TSBX vs TNMG Comparison

TSBX vs TNMG Comparison

Compare TSBX & TNMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • TNMG
  • Stock Information
  • Founded
  • TSBX 2015
  • TNMG 2023
  • Country
  • TSBX United States
  • TNMG Japan
  • Employees
  • TSBX N/A
  • TNMG N/A
  • Industry
  • TSBX
  • TNMG
  • Sector
  • TSBX
  • TNMG
  • Exchange
  • TSBX Nasdaq
  • TNMG NYSE
  • Market Cap
  • TSBX 8.4M
  • TNMG 9.2M
  • IPO Year
  • TSBX 2023
  • TNMG N/A
  • Fundamental
  • Price
  • TSBX $0.32
  • TNMG $0.30
  • Analyst Decision
  • TSBX Buy
  • TNMG
  • Analyst Count
  • TSBX 3
  • TNMG 0
  • Target Price
  • TSBX $4.75
  • TNMG N/A
  • AVG Volume (30 Days)
  • TSBX 89.5K
  • TNMG 2.0M
  • Earning Date
  • TSBX 05-12-2025
  • TNMG 01-01-0001
  • Dividend Yield
  • TSBX N/A
  • TNMG N/A
  • EPS Growth
  • TSBX N/A
  • TNMG N/A
  • EPS
  • TSBX N/A
  • TNMG N/A
  • Revenue
  • TSBX N/A
  • TNMG N/A
  • Revenue This Year
  • TSBX N/A
  • TNMG N/A
  • Revenue Next Year
  • TSBX N/A
  • TNMG N/A
  • P/E Ratio
  • TSBX N/A
  • TNMG N/A
  • Revenue Growth
  • TSBX N/A
  • TNMG N/A
  • 52 Week Low
  • TSBX $0.29
  • TNMG $0.28
  • 52 Week High
  • TSBX $3.39
  • TNMG $34.08
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 32.89
  • TNMG N/A
  • Support Level
  • TSBX $0.29
  • TNMG N/A
  • Resistance Level
  • TSBX $0.41
  • TNMG N/A
  • Average True Range (ATR)
  • TSBX 0.03
  • TNMG 0.00
  • MACD
  • TSBX -0.01
  • TNMG 0.00
  • Stochastic Oscillator
  • TSBX 23.39
  • TNMG 0.00

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About TNMG TNL MEDIAGENE

TNL Mediagene is a comprehensive media and data platform providing news and commentary on current events, business, technology, lifestyle and sports.

Share on Social Networks: